IDEAS home Printed from https://ideas.repec.org/a/igg/jrcm00/v6y2017i3p1-13.html
   My bibliography  Save this article

Applying Strategic Analysis to Quantify Investor Risk of Pfizer Pharmaceuticals

Author

Listed:
  • Brian J. Galli

    (Assistant Professor and Graduate Program Director, Master of Science in Engineering Management Industrial Engineering, Hofstra University, USA)

Abstract

This study analyzes Pfizer Pharmaceuticals, one of the leading pharmaceutical companies in the global market. A strategic analysis is presented in order to understand the liquidity, asset utilization, profitability, stability and debt management, and investor ratios of Pfizer. In this study, the strategic analysis is undergone, and each of the contributing factors is further explained. Suggestions about how management can mend and/or maintain the results in each factor of the strategic analysis are offered. The study concludes by suggesting whether or not it is viable for an equity investor to add Pfizer Pharmaceuticals to his/her portfolio of investments. Its contribution to future research is in the form of suggestions for management to take in order to mitigate financial risk and increase profitability.

Suggested Citation

  • Brian J. Galli, 2017. "Applying Strategic Analysis to Quantify Investor Risk of Pfizer Pharmaceuticals," International Journal of Risk and Contingency Management (IJRCM), IGI Global, vol. 6(3), pages 1-13, July.
    • Handle: RePEc:igg:jrcm00:v:6:y:2017:i:3:p:1-13
    as

    Download full text from publisher

    File URL: http://services.igi-global.com/resolvedoi/resolve.aspx?doi=10.4018/IJRCM.2017070101
    Download Restriction: no
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:igg:jrcm00:v:6:y:2017:i:3:p:1-13. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Journal Editor (email available below). General contact details of provider: https://www.igi-global.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.